US equities
|
MU
$1,031.00
▼-0.47%
TSLA
$383.81
▲+2.35%
NVDA
$229.78
▼-0.30%
SPCX
$162.51
▲+1.21%
AAPL
$335.08
▼-1.57%
SNDK
$1,605.43
▼-0.25%
AMD
$611.11
▼-1.54%
AMZN
$261.50
▲+2.93%
MU
$1,031.00
▼-0.47%
TSLA
$383.81
▲+2.35%
NVDA
$229.78
▼-0.30%
SPCX
$162.51
▲+1.21%
AAPL
$335.08
▼-1.57%
SNDK
$1,605.43
▼-0.25%
AMD
$611.11
▼-1.54%
AMZN
$261.50
▲+2.93%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about MedPharm
Recent news which mentions MedPharm
DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
December 06, 2024
Tickers
DEA
NEWS
Tags
Doctors for Drug Policy Reform
Matt Zorn
Politics
From
Benzinga
DEA Judge Blocks Researcher's Motion In Cannabis Rescheduling Case,
November 25, 2024
Tickers
DEA
NEWS
Tags
DEA
Government
Markets
From
Benzinga
MedPharm Cannabis Research In Alzheimer's Disease Gets Funding
July 21, 2022
Tags
Scott Karolchyk
FY23 Cannabis Research Opportunity
Market News
From
Benzinga